Correction: Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors [The Journal of Experimental Medicine, 1, (2018) 159-175] doi 10.1084/jem.20171052

Charalambos Kaittanis, Chrysafis Andreou, Haley Hieronymus, Ninghui Mao, Catherine A. Foss, Matthias Eiber, Gregor Weirich, Palak Panchal, Anuradha Gopalan, Juan Zurita, Samuel Achilefu, Gabriela Chiosis, Vladimir Ponomarev, Markus Schwaiger, Brett S. Carver, Martin G. Pomper, Jan Grimm

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Number of pages1
JournalJournal of Experimental Medicine
Volume215
Issue number1
StatePublished - Jan 1 2018

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Kaittanis, C., Andreou, C., Hieronymus, H., Mao, N., Foss, C. A., Eiber, M., Weirich, G., Panchal, P., Gopalan, A., Zurita, J., Achilefu, S., Chiosis, G., Ponomarev, V., Schwaiger, M., Carver, B. S., Pomper, M. G., & Grimm, J. (2018). Correction: Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors [The Journal of Experimental Medicine, 1, (2018) 159-175] doi 10.1084/jem.20171052. Journal of Experimental Medicine, 215(1).